Literature DB >> 20106771

Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease.

P Mouser1, M A Miller, E Antuofermo, S S Badve, S I Mohammed.   

Abstract

Mammary intraepithelial lesions (IELs) are noninvasive epithelial proliferations that include ductal hyperplasia (DH), atypical DH (ADH), and ductal carcinoma in situ (DCIS). In women, IELs are associated with increased risk of invasive breast cancer and form a basis for therapeutic decisions. Similarly, in female dogs, IELs are common in tumor-bearing glands and in non-tumor-bearing glands. To determine the prevalence and types of spontaneous IELs, mammary glands from 108 female dogs without clinical mammary disease were evaluated histologically and immunohistochemically. Within this population, 56 dogs (52%) had at least one type of spontaneous IEL, including DH (49 dogs), ADH (14 dogs), low-grade DCIS (19 dogs), intermediate-grade DCIS (12 dogs), and high-grade DCIS (1 dog). Twenty-one dogs had two or more different IEL types. In 23 of 24 dogs with atypical IELs (ADH or DCIS), immunohistochemical expression was determined for estrogen receptor alpha (ER-alpha), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2/neu), and Ki-67. For all markers examined, low-grade DCIS had significantly lower scores than did adjacent nonlesional gland; PR expression was significantly decreased in low-grade DCIS compared to other atypical lesions. Sixty-one lesions were ER-alpha negative (12 ADH, 36 low-grade DCIS, 13 intermediate-grade DCIS), and no lesions overexpressed HER-2/neu. Based on the dog's prevalence of spontaneous mammary IELs that precede clinical mammary disease, the remarkable histologic similarity between canine and human IELs, and the loss of ER expression in certain IELs in both species, the dog shows promise as a model for human breast preneoplasia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106771     DOI: 10.1177/0300985809358603

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  7 in total

1.  Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?

Authors:  G P Burrai; A Tanca; M R De Miglio; M Abbondio; S Pisanu; M Polinas; S Pirino; S I Mohammed; S Uzzau; M F Addis; E Antuofermo
Journal:  Tumour Biol       Date:  2015-06-19

2.  Morphological aspects and immunophenotypic profiles of mammary carcinomas in benign-mixed tumors of female dogs.

Authors:  Gustavo Meirelles Ribeiro; Angélica Cavalheiro Bertagnolli; Rafael Malagoli Rocha; Geovanni Dantas Cassali
Journal:  Vet Med Int       Date:  2012-09-13

3.  Elevated Krüppel-like factor 4 transcription factor in canine mammary carcinoma.

Authors:  Pei-Yi Chu; Nicholas Chung-Heng Hsu; Albert Taiching Liao; Kun-Tu Yeh; Ming-Feng Hou; Chen-Hsuan Liu
Journal:  BMC Vet Res       Date:  2011-10-07       Impact factor: 2.741

4.  Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma.

Authors:  Pei-Yi Chu; Nicholas C Hsu; Albert T Liao; Neng-Yao Shih; Ming-Feng Hou; Chen-Hsuan Liu
Journal:  BMC Vet Res       Date:  2011-10-21       Impact factor: 2.741

5.  A first immunohistochemistry study of transketolase and transketolase-like 1 expression in canine hyperplastic and neoplastic mammary lesions.

Authors:  Giovanni Pietro Burrai; Alessandro Tanca; Tiziana Cubeddu; Marcello Abbondio; Marta Polinas; Maria Filippa Addis; Elisabetta Antuofermo
Journal:  BMC Vet Res       Date:  2017-01-31       Impact factor: 2.741

6.  DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer.

Authors:  Megan Beetch; Sadaf Harandi-Zadeh; Tony Yang; Cayla Boycott; Yihang Chen; Barbara Stefanska; Sulma I Mohammed
Journal:  Sci Rep       Date:  2020-02-12       Impact factor: 4.379

7.  Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer.

Authors:  Sulma I Mohammed; Sagar Utturkar; Maxwell Lee; Howard H Yang; Zhibin Cui; Nadia Atallah Lanman; GuangJun Zhang; Xavier E Ramos Cardona; Suresh K Mittal; Margaret A Miller
Journal:  Cancers (Basel)       Date:  2020-02-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.